Dare Bioscience (DARE) EBT Margin (2016 - 2026)
Dare Bioscience's (DARE) quarterly EBT Margin came in at 159.91% in Q4 2025, down 856394.0% YoY from N/an in Q4 2024, and up 99.94% on a QoQ basis from 255665.25% in Q3 2025.
Dare Bioscience (DARE) EBT Margin (2016 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 6 years of EBT Margin data on file, last reported at 159.91% in Q4 2025.
- Quarterly EBT Margin fell 856394.0% year-over-year to 159.91% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1977.44% (up 24310307.0% YoY) and the FY2025 annual result came in at 12356.45%, up 140816158.0% from the prior year.
- EBT Margin grew to 159.91% in Q4 2025, from 255665.25% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 28092.76% in Q2 2025 to a low of 255665.25% in Q3 2025.
- A 4-year average of 32692.43% and a median of 850.19% in 2023 frame the typical range for EBT Margin.
- The widest YoY moves for EBT Margin: up 6186301 bps in 2025, down 24389072 bps in 2025.
- Tracing DARE's EBT Margin over 4 years: stood at 3.04% in 2022, then sank by 10227 bps to 308.18% in 2023, then soared by 2827 bps to 8404.02% in 2024, then slumped by 102 bps to 159.91% in 2025.
- The last three EBT Margin figures came in at 159.91% (Q4 2025), 255665.25% (Q3 2025), and 28092.76% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 | -1,582.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,075.20% |
| Dec 31, 2025 | -159.91% |
| Sep 30, 2025 | -255,665.25% |
| Jun 30, 2025 | 28,092.76% |
| Mar 31, 2025 | -27,543.54% |
| Dec 31, 2024 | 8,404.02% |
| Sep 30, 2024 | -11,774.54% |
| Jun 30, 2024 | -33,770.25% |
| Mar 31, 2024 | -66,044.70% |
| Dec 31, 2023 | -308.18% |
| Sep 30, 2023 | -850.19% |
| Jun 30, 2022 | 3.04% |
| Jun 30, 2017 | 49.66% |
| Mar 31, 2017 | -83.26% |
| Dec 31, 2016 | -81.68% |